C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

about

Novel Association of High C-Reactive Protein Levels and A69S at Risk Alleles in Wet Age-Related Macular Degeneration Women

P2860

Q58781252-BA249ABD-34DD-41A0-8A5A-396ABB694043

P2860

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

Item

http://www.wikidata.org/entity/Q54957842

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

@en

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

@nl

type

Item

label

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

@en

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

@nl

prefLabel

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

@en

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

@nl

P1476

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

@en

P2093

Alfredo Adan

http://www.w3.org/2001/XMLSchema#string

Andrew D Dick

http://www.w3.org/2001/XMLSchema#string

Blanca Molins

http://www.w3.org/2001/XMLSchema#string

Pablo Fuentes-Prior

http://www.w3.org/2001/XMLSchema#string

Sara Romero-Vázquez

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9

Complement factor H polymorphism in age-related macular degeneration

Age-dependent dysregulation of innate immunity

The physiological structure of human C-reactive protein and its complex with phosphocholine

Structural basis of ligand specificity in the human pentraxins, C-reactive protein and serum amyloid P component

Complement factor H variant increases the risk of age-related macular degeneration

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

Complement factor H polymorphism and age-related macular degeneration

C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes.

P304

808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3389/FIMMU.2018.00808

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29725335

http://www.w3.org/2001/XMLSchema#string

P921

albumins

blood proteins

age related macular degeneration

P932

5916960

http://www.w3.org/2001/XMLSchema#string

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

about

P2860

P2860

C-Reactive Protein as a Therapeutic Target in Age-Related Macular Degeneration.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P304

P31

P356

P478

P577

P698

P921

P932